M&A and capital advisory for health and medical technology companies.

Partner at Nelson Advisors, providing M&A, capital and strategy for healthcare technology companies.

Advising Family Offices, VC's and investors on portfolio companies and special situations. Typically CEO/CFO problem-solving, cap table fixing and deal structure, crisis management, fundraising + investability and stakeholder management

Combining wearable tech, AI and cutting-edge science to decode metabolic health, for everyone. Exited to Rio Health in 2024.

Providing advice to exciting start-up Unplugged on strategy, financing and operations.Unplugged is a fast-growing wellness brand offering digital detox experiences at easily accessible, beautiful cabins in the countryside around major urban centres.

Created and built a successful, profitable hospitality brand turning over in excess of $10m across 6 locations in 5 years. Sold majority stake in 2019 and exited in 2020. At the time of departure, we were the UK’s most successful independent "better" fried chicken business by sales volume and site expansion.

M&A and capital markets banker covering global financial institutions and fintechs.Landmark transactions included HM Treasury's investments in RBS, Lloyds and HBOS (£37bn) and the creation of the £280bn Asset Protection Scheme. £50+ billion of M&A transactions involving Barclays, HSBC, RBS, ANZ Bank (Australia), Intesa SanPaolo, UniCredit, OMX Group, Swiss Re/Brevan Howard, KKR, Cerberus, Advent International (Equiniti) and Apax Partners (Travelex). £40+ billion of equity/financing transactions involving clients such as HSBC, Barclays, Bank of Ireland, Sberbank, Alfa Bank, Renaissance Capital, and National Bank of Greece.